Authors:
Masquelier, B
Chaix, ML
Burgard, M
Lechenadec, J
Doussin, A
Simon, F
Cottalorda, J
Izopet, J
Tamalet, C
Douard, D
Fleury, H
Mayaux, MJ
Blanche, S
Rouzioux, C
Citation: B. Masquelier et al., Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort, J ACQ IMM D, 27(2), 2001, pp. 99-104
Authors:
Degos, F
Pol, S
Chaix, ML
Laffitte, V
Buffet, C
Bernard, PH
Degott, C
Carnot, F
Riffaud, PC
Chevret, S
Citation: F. Degos et al., The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study, NEPH DIAL T, 16(5), 2001, pp. 1017-1023
Authors:
Mandelbrot, L
Landreau-Mascaro, A
Rekacewicz, C
Berrebi, A
Benifla, JL
Burgard, M
Lachassine, E
Barret, B
Chaix, ML
Bongain, A
Ciraru-Vigneron, N
Crenn-Hebert, C
Delfraissy, JF
Rouzioux, C
Mayaux, MJ
Blanche, S
Citation: L. Mandelbrot et al., Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1, J AM MED A, 285(16), 2001, pp. 2083-2093
Authors:
Buseyne, F
Chaix, ML
Rouzioux, C
Blanche, S
Riviere, Y
Citation: F. Buseyne et al., Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24(gag) epitope by HIV-1-infected children, J VIROLOGY, 75(10), 2001, pp. 4941-4946
Authors:
Casado, C
Urtasun, I
Saragosti, S
Chaix, ML
De Rossi, A
Cattelan, AM
Dietrich, U
Lopez-Galindez, C
Citation: C. Casado et al., Different distribution of HIV type 1 genetic variants in European patientswith distinct risk practices, AIDS RES H, 16(3), 2000, pp. 299-304
Authors:
Chaix, ML
Manigart, O
Letourneur, F
Burgard, M
Mayaux, MJ
Rouzioux, C
Citation: Ml. Chaix et al., Diversity of HIV-1 genetic subtypes in France, in the context of mother-to-child transmission, AIDS, 14(3), 2000, pp. 327-328
Authors:
Fontaine, H
Chaix, ML
Lagneau, JL
Brechot, C
Pol, S
Citation: H. Fontaine et al., Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa, LANCET, 356(9223), 2000, pp. 41-41
Authors:
Zylberberg, H
Benhamou, Y
Lagneaux, JL
Landau, A
Chaix, ML
Fontaine, H
Bochet, M
Poynard, T
Katlama, C
Pialoux, G
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIVcoinfected subjects: an early report, GUT, 47(5), 2000, pp. 694-697
Citation: H. Zylberberg et al., Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha, ANN INT MED, 132(10), 2000, pp. 845-846
Authors:
Zylberberg, H
Pol, S
Thiers, V
Chaix, ML
Lagorce, D
Brechot, C
Nalpas, B
Berthelot, P
Citation: H. Zylberberg et al., Significance of repeatedly normal aminotransferase activities in HCV-infected patients, J CLIN GAST, 29(1), 1999, pp. 71-75